Topic: Gut Microbiome and Metabolic Diseases
A Special Issue of Microbiome Research Reports
ISSN 2771-5965 (Online)
Submission deadline: 31 Oct 2025
Guest Editor(s)
Prof. Jie Yin
College of Animal Science and Technology, Hunan Agricultural University, Changsha, Hunan, China.
Special Issue Introduction
The gut microbiota consists of a complex community of microorganisms, including bacteria, fungi, viruses, and archaea. Advances in microbiome research and metagenomics have greatly enhanced our understanding of the gut microbiota, with recent studies revealing that gut microbes are closely linked to host health, especially in relation to metabolic diseases.
Metabolic diseases, such as obesity, type 2 diabetes, non-alcoholic fatty liver disease, and cardiovascular disease, arise from metabolic disorders and persist over time or may even be lifelong. Studies have shown that metabolic diseases are related to genetics, dietary habits, lifestyle choices, environmental influences, and other factors; importantly, gut microbiota has been identified as one of the significant contributors.
Understanding the role of gut microbiota in the development of metabolic diseases, as well as how they can be leveraged to prevent these diseases, has significant implications for treatment strategies. Long-term drug treatments, for instance, may alter the diversity and abundance of microbes, potentially impacting host health. New microbial sequencing and experimental techniques are now enabling deeper insights into gut microbiota function and the mechanisms through which microbial metabolites contribute to metabolic diseases.
This Special Issue of Microbiome Research Reports will present recent findings on this topic. We aim to explore the roles of gut microbiota in the development of metabolic diseases, and to identify specific microorganisms that could be targeted for the prevention and treatment of these conditions through microbial interventions.
Topics in this Special Issue will include, but are not limited to:
1. Changes in gut microbiota and their roles in the development of metabolic diseases;
2. Screening and identification of gut microbiota for the prevention and treatment of metabolic diseases, and insights into related regulatory mechanisms;
3. The impact of gut microbiota during drug treatment for metabolic diseases;
4. The influence of lifestyle factors (dietary habits, lifestyle choices, environmental exposures) on gut microbes and metabolic diseases.
Metabolic diseases, such as obesity, type 2 diabetes, non-alcoholic fatty liver disease, and cardiovascular disease, arise from metabolic disorders and persist over time or may even be lifelong. Studies have shown that metabolic diseases are related to genetics, dietary habits, lifestyle choices, environmental influences, and other factors; importantly, gut microbiota has been identified as one of the significant contributors.
Understanding the role of gut microbiota in the development of metabolic diseases, as well as how they can be leveraged to prevent these diseases, has significant implications for treatment strategies. Long-term drug treatments, for instance, may alter the diversity and abundance of microbes, potentially impacting host health. New microbial sequencing and experimental techniques are now enabling deeper insights into gut microbiota function and the mechanisms through which microbial metabolites contribute to metabolic diseases.
This Special Issue of Microbiome Research Reports will present recent findings on this topic. We aim to explore the roles of gut microbiota in the development of metabolic diseases, and to identify specific microorganisms that could be targeted for the prevention and treatment of these conditions through microbial interventions.
Topics in this Special Issue will include, but are not limited to:
1. Changes in gut microbiota and their roles in the development of metabolic diseases;
2. Screening and identification of gut microbiota for the prevention and treatment of metabolic diseases, and insights into related regulatory mechanisms;
3. The impact of gut microbiota during drug treatment for metabolic diseases;
4. The influence of lifestyle factors (dietary habits, lifestyle choices, environmental exposures) on gut microbes and metabolic diseases.
Submission Deadline
31 Oct 2025
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/mrr/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=mrr&SpecialIssueId=MRR241107
Submission Deadline: 31 Oct 2025
Contacts: Fiona Yin, Managing Editor, editorialoffice@mrrjournal.net
